Thebaine Derivatives as a New Regulator of Tumor Angiogenesis

References

• Ingo Flamme, Thomas Frölich, and Werner Risau, “Molecular Mechanisms of Vasculogenesis and Embryonic Angiogenesis,” Journal of Cellular Physiology 173, no. 2 (1997): 206–10.
   PubMed Web of Science ®Google Scholar
• Judah Folkman, “Role of Angiogenesis in Tumor Growth and Metastasis,” Seminars in Oncology 29, no. 6Q (2002): 15–8.
   PubMedGoogle Scholar
• Rakesh K. Jain, “Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers,” Journal of Clinical Oncology 31, no. 17 (2013): 2205–18.
   PubMed Web of Science ®Google Scholar
• Rakesh K. Jain, “Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia,” Cancer Cell 26, no. 5 (2014): 605–22.
   PubMed Web of Science ®Google Scholar
• Kyrre E. Emblem, Kim Mouridsen, Atle Bjornerud, Christian T. Farrar, Dominique Jennings, Ronald J. H. Borra, Patrick Y. Wen, Percy Ivy, Tracy T. Batchelor, Bruce R. Rosen, et al. “Vessel Architectural Imaging Identifies Cancer Patient Responders to anti-Angiogenic Therapy,” Nature Medicine 19, no. 9 (2013): 1178–83.
   PubMed Web of Science ®Google Scholar
• Melissa M. Keenan, and Jen-Tsan Chi, “Alternative Fuels for Cancer Cells,” Cancer Journal (Sudbury, Mass.) 21, no. 2 (2015): 49–55.
   PubMed Web of Science ®Google Scholar
• Elizabeth C. Finger, and Amato J. Giaccia, “Hypoxia, Inflammation, and the Tumor Microenvironment in Metastatic Disease,” Cancer Metastasis Reviews 29, no. 2 (2010): 285–93.
   PubMed Web of Science ®Google Scholar
• Gregg L. Semenza, “Hypoxia-Inducible Factors: Mediators of Cancer Progression and Targets for Cancer Therapy,” Trends in Pharmacological Sciences 33, no. 4 (2012): 207–14.
   PubMed Web of Science ®Google Scholar
• Astrid A. M. Van der Veldt, Mark Lubberink, Idris Bahce, Maudy Walraven, Michiel P. de Boer, Henri N. J. M. Greuter, N. Harry Hendrikse, Jonas Eriksson, Albert D. Windhorst, Pieter E. Postmus, et al. “Rapid Decrease in Delivery of Chemotherapy to Tumors after anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs,” Cancer Cell 21, no. 1 (2012): 82–91.
   PubMed Web of Science ®Google Scholar
• Vikash P. Chauhan, John D. Martin, Hao Liu, Delphine A. Lacorre, Saloni R. Jain, Sergey V. Kozin, Triantafyllos Stylianopoulos, Ahmed S. Mousa, Xiaoxing Han, Pichet Adstamongkonkul, et al. “Angiotensin Inhibition Enhances Drug Delivery and Potentiates Chemotherapy by Decompressing Tumour Blood Vessels,” Nature Communications 4, no. 4 (2013): 2516.,
   PubMedGoogle Scholar
• Vasiliki Gkretsi, Andreas Stylianou, Panagiotis Papageorgis, Christiana Polydorou, and Triantafyllos Stylianopoulos, “Remodeling Components of the Tumor Microenvironment to Enhance Cancer Therapy,” Frontiers in Oncology 5, no. 5 (2015): 214.
   PubMedGoogle Scholar
• Tracy T. Batchelor, Elizabeth R. Gerstner, Kyrre E. Emblem, Dan G. Duda, Jayashree Kalpathy-Cramer, Matija Snuderl, Marek Ancukiewicz, Pavlina Polaskova, Marco C. Pinho, Dominique Jennings, et al. “Improved Tumor Oxygenation and Survival in Glioblastoma Patients Who Show Increased Blood Perfusion after Cediranib and Chemoradiation,” Proceedings of the National Academy of Sciences of the United States of America 110, no. 47 (2013): 19059–64.
   PubMed Web of Science ®Google Scholar
• Argelia Lara-Solares, Marisol Ahumada Olea, Amparito de Los Ángeles Basantes Pinos, Sara Bistre Cohén, Patricia Bonilla Sierra, Eva Rossina Duarte Juárez, Omar A. Símon Escudero, Juan Guillermo Santacruz Escudero, and José Alberto Flores Cantisani, “Latin-American Guidelines for Cancer Pain Management,” Pain Management 7, no. 4 (2017): 287–98.
   PubMed Web of Science ®Google Scholar
• P. A. Singleton, M. W. Lingen, M. J. Fekete, J. G. N. Garcia, and J. Moss, “Methylnaltrexone Inhibits Opiate and VEGF-Induced Angiogenesis: Role of Receptor Transactivation,” Microvascular Research 72, no. 1–2 (2006): 3–11.
   PubMed Web of Science ®Google Scholar
• J. Nguyen, K. Luk, D. Vang, W. Soto, L. Vincent, S. Robiner, R. Saavedra, Y. Li, P. Gupta, and K. Gupta, “Morphine Stimulates Cancer Progression and Mast Cell Activation and Impairs Survival in Transgenic Mice with Breast Cancer,” British Journal of Anaesthesia 113, no. 113 (2014): i4–13.
   PubMedGoogle Scholar
• M. Farooqui, Y. Li, T. Rogers, T. Poonawala, R. J. Griffin, C. W. Song, and K. Gupta, “COX-2 Inhibitor Celecoxib Prevents Chronic Morphine-Induced Promotion of Angiogenesis, Tumour Growth, Metastasis and Mortality, without Compromising Analgesia,” British Journal of Cancer 97, no. 11 (2007): 1523–31.
   PubMed Web of Science ®Google Scholar
• Raja M. Abdel-Majid, and Jean S. Marshall, “Prostaglandin E2 Induces Degranulation-Independent Production of Vascular Endothelial Growth Factor by Human Mast Cells,” Journal of Immunology (Baltimore, Md.: 1950) 172, no. 2 (2004): 1227–36.
   PubMed Web of Science ®Google Scholar
• Lisa Koodie, Hongyan Yuan, Jeffery A. Pumper, Haidong Yu, Richard Charboneau, Sundaram Ramkrishnan, and Sabita Roy, “Morphine Inhibits Migration of Tumor-Infiltrating Leukocytes and Suppresses Angiogenesis Associated with Tumor Growth in Mice,” The American Journal of Pathology 184, no. 4 (2014): 1073–84.
   PubMed Web of Science ®Google Scholar
• Samira Khabbazi, Zeyad D. Nassar, Yannick Goumon, and Marie-Odile Parat, “Morphine Decreases the Pro-Angiogenic Interaction between Breast Cancer Cells and Macrophages in Vitro,” Scientific Reports 6, no. 6 (2016): 31572.
   PubMedGoogle Scholar
• Lisa Koodie, Sundaram Ramakrishnan, and Sabita Roy, “Morphine Suppresses Tumor Angiogenesis through a HIF-1alpha/p38MAPK Pathway,” The American Journal of Pathology 177, no. 2 (2010): 984–97.
   PubMed Web of Science ®Google Scholar
• Sudha Balasubramanian, Sundaram Ramakrishnan, Richard Charboneau, Jinghua Wang, Roderick A. Barke, and Sabita Roy, “Morphine Sulfate Inhibits Hypoxia-Induced Vascular Endothelial Growth Factor Expression in Endothelial Cells and Cardiac Myocytes,” Journal of Molecular and Cellular Cardiology 33, no. 12 (2001): 2179–87.
   PubMed Web of Science ®Google Scholar
• Abbas Shafiee, Massoud Amanlou, Hassan Farsam, Ahmad Reza Dehpour, F. Mir-Ershadi, and Alireza Mani, “Synthesis and Pharmacological Activity of Thebaine-Derived μ-Opioid Receptor Agonists,” Pharmaceutica Acta Helvetiae 73, no. 5 (1999): 251–4.
   PubMedGoogle Scholar
• Niusha Sharifi, Effat Souri, Seyed Ali Ziai, Gholamreza Amin, Mohsen Amini, and Massoud Amanlou, “Isolation, Identification and Molecular Docking Studies of a New Isolated Compound, from Onopordon Acanthium: A Novel Angiotensin Converting Enzyme (ACE) Inhibitor,” Journal of Ethnopharmacology 148, no. 3 (2013): 934–9.
   PubMed Web of Science ®Google Scholar
• Garrett M. Morris, Ruth Huey, William Lindstrom, Michel F. Sanner, Richard K. Belew, David S. Goodsell, and Arthur J. Olson, “Autodock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexiblity,” Journal of Computational Chemistry 30, no. 16 (2009): 2785–91.
   PubMed Web of Science ®Google Scholar
• Xu Dai, Hong-jin Song, Shi-gang Cui, Ting Wang, Qian Liu, and Rui Wang, “The Stimulative Effects of Endogenous Opioids on Endothelial Cell Proliferation, Migration and Angiogenesis in Vitro,” European Journal of Pharmacology 628, no. 1–3 (2010): 42–50.
   PubMed Web of Science ®Google Scholar
• Michel Barrot, “Tests and Models of Nociception and Pain in Rodents,” Neuroscience 211, no. 211 (2012): 39–50.
   PubMedGoogle Scholar
• Tsutomu Suzuki, Takuko Sawada, Koji Kawai, and Yasunobu Ishihara, “Pharmacological Profile of TAN-452, a Novel Peripherally Acting Opioid Receptor Antagonist for the Treatment of Opioid-Induced Bowel Syndromes,” Life Sciences 215, no. 215 (2018): 246–52.
   PubMedGoogle Scholar
• E. E. Shults, M. M. Shakirov, G. A. Tolstikov, V. N. Kalinin, and G. Schmidhammer, “Thebaine Adducts with Maleimides. Synthesis and Transformations,” Russian Journal of Organic Chemistry 41, no. 8 (2005): 1132–44.
   Web of Science ®Google Scholar
• Teresa Kaserer, Aquilino Lantero, Helmut Schmidhammer, Mariana Spetea, and Daniela Schuster, “μ Opioid Receptor: Novel Antagonists and Structural Modeling,” Scientific Reports 6, no. 6 (2016): 21548.
   PubMedGoogle Scholar
• Parker W. De Waal, Jingjing Shi, Erli You, Xiaoxi Wang, Karsten Melcher, Yi Jiang, H. Eric Xu, and Bradley M. Dickson, “Molecular Mechanisms of Fentanyl Mediated β-Arrestin Biased Signaling,” PLoS Computational Biology 16, no. 4 (2020): e1007394. ‏
   PubMed Web of Science ®Google Scholar
• John Blebea, James E. Mazo, Todd K. Kihara, Jonathan-Hien Vu, Patricia J. McLaughlin, Robert G. Atnip, and Ian S. Zagon, “Opioid Growth Factor Modulates Angiogenesis,” Journal of Vascular Surgery 32, no. 2 (2000): 364–73.
   PubMed Web of Science ®Google Scholar
• Andrew P. Feinberg, Ian Creese, and Solomon H. Snyder, “The Opiate Receptor: A Model Explaining Structure-Activity Relationships of Opiate Agonists and Antagonists,” Proceedings of the National Academy of Sciences of the United States of America 73, no. 11 (1976): 4215–9.
   PubMed Web of Science ®Google Scholar
• Yan Wu, Patricia J. Mclaughlin, and Ian S. Zagon, “Ontogeny of the Opioid Growth Factor,[Met5]‐Enkephalin, Preproenkephalin Gene Expression, and the ζ Opioid Receptor in the Developing and Adult Aorta of Rat,” Developmental Dynamics 211, no. 4 (1998): 327–37.
   PubMed Web of Science ®Google Scholar
• Ian S. Zagon, Yan Wu, and Patricia J. McLaughlin, “Opioid Growth Factor-Dependent DNA Synthesis in the Neonatal Rat Aorta,” The American Journal of Physiology 270, no. 1 Pt 2 (1996): R22–32.
   PubMedGoogle Scholar
• Xu Dai, Shi-gang Cui, Ting Wang, Qian Liu, Hong-jin Song, and Rui Wang, “Endogenous Opioid Peptides, Endomorphin-1 and -2 and Deltorphin I, Stimulate Angiogenesis in the CAM Assay,” European Journal of Pharmacology 579, no. 1–3 (2008): 269–75.
   PubMed Web of Science ®Google Scholar
• Banafsheh Afsharimani, Peter Cabot, and Marie-Odile Parat, “Morphine and Tumor Growth and Metastasis,” Cancer Metastasis Reviews 30, no. 2 (2011): 225–38.
   PubMed Web of Science ®Google Scholar
• Martina Ondrovics, Andrea Hoelbl-Kovacic, and Daniela Alexandra Fux, “Opioids: Modulators of Angiogenesis in Wound Healing and Cancer,” Oncotarget 8, no. 15 (2017): 25783–96.
   PubMedGoogle Scholar
• George B. Stefano, Alan Hartman, Thomas V. Bilfinger, Harold I. Magazine, Yu Liu, Federico Casares, and Michael S. Goligorsky, “Presence of the mu3 Opiate Receptor in Endothelial Cells Coupling to Nitric Oxide Production and Vasodilation,” The Journal of Biological Chemistry 270, no. 51 (1995): 30290–3.
   PubMed Web of Science ®Google Scholar
• Caterina Fimiani, Dwight Mattocks, Francesco Cavani, Michel Salzet, Dale G. Deutsch, Stephen Pryor, Thomas V. Bilfinger, and George B. Stefano, “Morphine and Anandamide Stimulate Intracellular Calcium Transients in Human Arterial Endothelial Cells: Coupling to Nitric Oxide Release,” Cellular Signalling 11, no. 3 (1999): 189–93.
   PubMed Web of Science ®Google Scholar
• Kalpna Gupta, Smita Kshirsagar, Liming Chang, Robert Schwartz, Ping-Y. Law, Doug Yee, and Robert P. Hebbel, “Morphine Stimulates Angiogenesis by Activating Proangiogenic and Survival-Promoting Signaling and Promotes Breast Tumor Growth,” Cancer Research no. 62 (2002): 4491–8.
   PubMedGoogle Scholar
• Chen-Fuh Lam, Pei-Jung Chang, Yu-Sheng Huang, Yen-Hui Sung, Chien-Chi Huang, Ming-Wei Lin, Yen-Chin Liu, and Yu-Chuan Tsai, “Prolonged Use of High-Dose Morphine Impairs Angiogenesis and Mobilization of Endothelial Progenitor Cells in Mice,” Anesthesia and Analgesia 107, no. 2 (2008): 686–92.
   PubMed Web of Science ®Google Scholar
• Aurelio Pasi, Baoxi Qu, Rudolf Steiner, Hans-Jörg Senn, Walter Bär, and Fathy S. Messiha, “Angiogenesis: Modulation with Opioids,” General Pharmacology 22, no. 6 (1991): 1077–9.
   PubMedGoogle Scholar
• Po-Ni Hsiao, Ming-Cheng Chang, Wen-Fang Cheng, Chi-An Chen, Han-Wei Lin, Chang-Yao Hsieh, and Wei-Zen Sun, “Morphine Induces Apoptosis of Human Endothelial Cells through Nitric Oxide and Reactive Oxygen Species Pathways,” Toxicology 256, no. 1–2 (2009): 83–91.
   PubMed Web of Science ®Google Scholar
• Negar Faramarzi, Ata Abbasi, Seyed M. Tavangar, Marjan Mazouchi, and Ahmad R. Dehpour, “Opioid Receptor Antagonist Promotes Angiogenesis in Bile Duct Ligated Rats,” Journal of Gastroenterology and Hepatology 24, no. 7 (2009): 1226–9.
   PubMed Web of Science ®Google Scholar